These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4150986)

  • 1. Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter.
    Dorris RL; Shore PA
    Biochem Pharmacol; 1974 Feb; 23(4):867-72. PubMed ID: 4150986
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
    Zivkovic B; Guidotti A
    Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of neuroleptics and of combinations of d-amphetamine and neuroleptics on 3H-dopamine uptake by homogenates from rat striatum.
    Del Rio J; Madroñal J
    Eur J Pharmacol; 1976 Oct; 39(2):267-74. PubMed ID: 976322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.
    Honma T; Fukushima H
    Neuropharmacology; 1976 Oct; 15(10):601-7. PubMed ID: 1033478
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.
    Iversen LL; Rogawski MA; Miller RJ
    Mol Pharmacol; 1976 Mar; 12(2):251-62. PubMed ID: 4724
    [No Abstract]   [Full Text] [Related]  

  • 6. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.
    Burt DR; Creese I; Snyder SH
    Science; 1977 Apr; 196(4287):326-8. PubMed ID: 847477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of amfonelic acid in rats: a comparison with amphetamine and apomorphine.
    Jeste DV; Perlow MJ; Wyatt RJ; Stoff DM
    Commun Psychopharmacol; 1979; 3(1):41-7. PubMed ID: 38031
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
    van der Elst MC; Wunderink YS; Ellenbroek BA; Cools AR
    Psychopharmacology (Berl); 2007 Jan; 190(1):93-102. PubMed ID: 17031706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
    Van Rossum JM
    Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
    Randrup A
    Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic neuronal responses to a non-amphetamine CNS stimulant.
    German DC; Harden H; Sanghera MK; Mann D; Kiser RS; Miller HH; Shore PA
    J Neural Transm; 1979; 44(1-2):39-49. PubMed ID: 35584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term control of tyrosine hydroxylase.
    Carlsson A; Kehr W; Lindqvist M
    Adv Biochem Psychopharmacol; 1974; 12(0):135-42. PubMed ID: 4154020
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of CNS stimulants with phencyclidine on dopamine release using in vivo voltammetry.
    Howard-Butcher S; Blaha CD; Lane RF
    Brain Res Bull; 1984 Oct; 13(4):497-501. PubMed ID: 6151866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on hypothalamic self-stimulation of drugs influencing dopaminergic neurotransmission injected into nucleus accumbens and corpus striatum of rats.
    Stephens DN; Herberg LJ
    Psychopharmacology (Berl); 1977 Aug; 54(1):81-5. PubMed ID: 198840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dopaminergic mechanism mediates the d-amphetamine- and apomorphine-induced increase of ascorbic acid metabolism in the rat striatum.
    Miele M; Desole MS; Enrico P; Esposito G; De Natale G; Miele E
    Pharmacol Res; 1990; 22 Suppl 3():41-2. PubMed ID: 2097636
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of butaclamol and of other neuroleptic agents on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity.
    Bronaugh RL; Tabak J; Ohashi T; Goldstein M
    Psychopharmacol Commun; 1975; 1(5):501-10. PubMed ID: 7003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.
    Vonvoigtlander PF; Losey EG; Triezenberg HJ
    J Pharmacol Exp Ther; 1975 Apr; 193(1):88-94. PubMed ID: 166158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.
    Christiansen J; Squires RF
    J Pharm Pharmacol; 1974 May; 26(5):367-9. PubMed ID: 4152779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.